Multiple system atrophy, or MSA, is a rare neurodegenerative disorder with symptoms akin to ALS or Parkinson’s disease in the ...

From breakfast to dinner, ultra-processed foods are everywhere. They're the quick and easy fix we all crave, but are they ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients' quality of life over time. It causes neuropsychiatric disorders and ...

Alzheimer's disease, a devastating neurodegenerative condition that affects millions of people worldwide, may have found a ...

MADRID — Patients with type 2 diabetes treated with sodium-glucose cotransporter 2 inhibitors (SGLT2is) show significant ...

Researchers have for the first time identified degeneration-associated 'molecular markers' -- observable changes in cells and their gene-regulating networks -- that are shared by several forms of ...

Enigma Biomedical USA (EB) today announced a collaboration with Alamar Biosciences in the field of neurology. Through this collaboration, EB has a non-exclusive right to introduce Alamar’s protein ...

Clene (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is making ...

Here’s the full list of participants. Next up, the company is accepting applications for a cohort focused on a specific therapeutic area: neurological diseases. “Neurological diseases are an ...